David W. Kimmel

Mayo Clinic

Papers

2

Total Citations

296

H-Index

2

About

David W. Kimmel is a pioneering neuro-oncologist whose work has fundamentally shaped our understanding of the genetic underpinnings of brain tumors. His primary research focuses on the cytogenetics of human gliomas and cerebral astrocytomas, where he has made landmark contributions to the field. Kimmel’s seminal 1989 study, “A cytogenetic study of 53 human gliomas,” with 247 citations, provided one of the earliest and most comprehensive chromosomal analyses of these aggressive tumors, establishing critical links between specific genetic abnormalities and tumor behavior. He further advanced the field with his 1992 work on the prognostic value of cytogenetic analysis in astrocytomas (49 citations), demonstrating that chromosomal markers could predict patient outcomes—a concept that was revolutionary for solid tumors at a time when such analysis was primarily used in hematological malignancies. By integrating cytogenetics into neuro-oncology, Kimmel helped pave the way for modern molecular diagnostics and personalized treatment strategies, leaving a lasting impact on how researchers and clinicians approach brain tumor classification and prognosis.

Research Focus

Key Achievements

2
H-Index
2
Papers
296
Total Citations
148
Avg Citations/Paper
🏆 Most Cited Paper
A cytogenetic study of 53 human gliomas
247 citations · 1989
📈 Most Prolific Year: 1989 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago